GF Gjerset

481 citations
19 papers · 352 indexed · h-index 11
Topics
Blood groups and transfusion (9 papers)HIV Research and Treatment (7 papers)Platelet Disorders and Treatments (5 papers)

In The Last Decade

GF Gjerset

18 papers receiving 329 citations

Peers

GF Gjerset
Comparison fields: 5 of 66
  • Immunology 157
  • Virology 156
  • Infectious Diseases 99
  • Hematology 80
  • Epidemiology 79
Replace T J Spira with:
T J Spira United States
R. Samuel Hopkins United States
Indira K. Hewlett United States
R Pahwa United States
DB Brettler United States
O. López Spain
Katija Jelicic United States
Laura Tarancón‐Díez Spain
Peter Gowland Switzerland
Cecilia M. O’Brien United States
GF Gjerset relative to T J Spira United States T J Spira's profile →
Citations per field
00.5×3.1×
T J Spira · 1×
Citations per year

Countries citing papers authored by GF Gjerset

Since Specialization
Citations

This map shows the geographic impact of GF Gjerset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GF Gjerset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GF Gjerset more than expected).

Fields of papers citing papers by GF Gjerset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GF Gjerset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GF Gjerset. The network helps show where GF Gjerset may publish in the future.

Co-authorship network of co-authors of GF Gjerset

This figure shows the co-authorship network connecting the top 25 collaborators of GF Gjerset. A scholar is included among the top collaborators of GF Gjerset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GF Gjerset. GF Gjerset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 16
2 27
3 10
4 9
5 20
6 11
7 22
8 20
9
Lymphocyte Proliferation Assays
45
10 10
11
Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study Group.
6
12 3
13 103
14 15
15 0
16 17
17 1
18 16
19 1

About GF Gjerset

GF Gjerset is a scholar working on Virology, Hematology and Immunology, having authored 19 papers that have together received 352 indexed citations. Recurring topics across this work include Blood groups and transfusion (9 papers), HIV Research and Treatment (7 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Virology (156 citations), Immunology (157 citations) and Hematology (80 citations). GF Gjerset has collaborated with scholars based in United States, South Africa and Croatia. Frequent co-authors include Patricia Morán, J. W. Eichberg, J M Zarling, Patricia N. Fultz, J A Ledbetter, Mary A Fletcher, J. W. Mosley, Nancy G. Klimas, Raymond F. Morgan and Joseph M. Hassett. Their work appears in journals such as Blood, The Journal of Immunology and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026